Viewing Study NCT04366232


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-01 @ 6:51 PM
Study NCT ID: NCT04366232
Status: TERMINATED
Last Update Posted: 2020-12-16
First Post: 2020-04-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module